Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen (2018)
- Authors:
- USP affiliated authors: VELLOSO, ELVIRA DEOLINDA RODRIGUES PEREIRA - FM ; ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1016/j.clml.2018.03.001
- Subjects: LEUCEMIA MIELOIDE AGUDA; EVENTO ADVERSO A MEDICAMENTO; MORTALIDADE; FARMACOTERAPIA; BRASIL
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical lymphoma myeloma & leukemia
- ISSN: 2152-2650
- Volume/Número/Paginação/Ano: v. 18, n. 6, p. E255-E259, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA JUNIOR, Wellington Fernandes da e VELLOSO, Elvira D. R. P. e ROCHA, Vanderson. Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen. Clinical lymphoma myeloma & leukemia, v. 18, n. 6, p. E255-E259, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.clml.2018.03.001. Acesso em: 28 dez. 2025. -
APA
Silva Junior, W. F. da, Velloso, E. D. R. P., & Rocha, V. (2018). Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen. Clinical lymphoma myeloma & leukemia, 18( 6), E255-E259. doi:10.1016/j.clml.2018.03.001 -
NLM
Silva Junior WF da, Velloso EDRP, Rocha V. Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen [Internet]. Clinical lymphoma myeloma & leukemia. 2018 ; 18( 6): E255-E259.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.clml.2018.03.001 -
Vancouver
Silva Junior WF da, Velloso EDRP, Rocha V. Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen [Internet]. Clinical lymphoma myeloma & leukemia. 2018 ; 18( 6): E255-E259.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.clml.2018.03.001 - Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia
- Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience
- Outcomes and second neoplasms in hairy cell leukemia: a retrospective cohort
- Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation
- Real-life outcomes on acute promyelocytic leukemia in Brazil - early deaths are still a problem
- The impact of clinical features on survival and relapse of patients diagnosed with T-cell acute lymphoblastic leukemia: a multicenter cohort study
- Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting
- Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia
- Assessing the role of bronchoscopy in the management of patients with acute leukemia-a transversal study and proposal of evaluation
- Toxicity profile of PEG-asparaginase in adult patients with acute lymphoblastic leukemia in Brazil: a multicenter cross-sectional study
Informações sobre o DOI: 10.1016/j.clml.2018.03.001 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
